Related Experiment Videos
IgG subclass antibody markers in grass pollen immunotherapy.
1Department of Pediatrics, Stanford University Medical School, CA.
New England and Regional Allergy Proceedings
|November 1, 1987
Summary
Rye grass immunotherapy effectively treats allergic asthma by altering antibody levels. It reduces allergic IgE antibodies while significantly increasing blocking IgG antibodies, particularly IgG4.
Area of Science:
- Immunology
- Allergy Research
- Respiratory Medicine
Background:
- Seasonal allergic asthma affects many individuals, often triggered by environmental allergens like rye grass.
- Current treatments focus on symptom management, but allergen-specific immunotherapy offers a potential disease-modifying approach.
- Understanding the immunologic changes induced by immunotherapy is crucial for optimizing treatment strategies.
Purpose of the Study:
- To evaluate the clinical efficacy of rye grass immunotherapy in seasonal allergic asthma.
- To characterize the serologic changes, specifically antibody responses, induced by rye grass immunotherapy.
- To compare immunotherapy-induced antibody profiles with those from natural allergen exposure and non-allergic individuals.
Main Methods:
- Clinical assessment of symptom and medication scores in patients undergoing rye grass immunotherapy.
- Measurement of specific IgE and IgG (including IgG1 and IgG4 subclasses) antibody levels against rye grass antigens.
- Analysis of IgE and IgG binding capacities of various rye grass allergens and antigens.
Main Results:
- Rye grass immunotherapy demonstrated clinical effectiveness in seasonal allergic asthma.
- Immunotherapy blunted the seasonal increase in IgE antibodies and significantly elevated blocking IgG antibodies, predominantly IgG4.
- Blocking antibody responses were specific to IgG1 and IgG4 subclasses, with IgG4 showing a more dramatic increase.
- Rye grass extract contained multiple IgE and IgG binding antigens, with antigen I being most significant.
- A potential role for IgG1 in early clinical benefits was suggested by an inverse correlation with symptom scores.
Conclusions:
- Rye grass immunotherapy is clinically effective for seasonal allergic asthma, inducing distinct serologic changes.
- The dominant IgG4 response suggests a key mechanism for blocking allergen-induced reactions.
- Further research into the differential roles of IgG1 and IgG4 in immunotherapy response is warranted.